Detalhe da pesquisa
1.
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program.
Antimicrob Agents Chemother;
67(7): e0019423, 2023 07 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37347188
2.
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies.
Clin Infect Dis;
75(6): 1081-1084, 2022 09 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35148378
3.
Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study.
Eur J Clin Microbiol Infect Dis;
41(3): 467-476, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35025025
4.
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
N Engl J Med;
379(10): 913-923, 2018 09 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30184455
5.
Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
J Antimicrob Chemother;
76(11): 2902-2905, 2021 10 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34383901
6.
Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
J Infect Dis;
221(3): 346-355, 2020 01 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31309975
7.
Erratum to: Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
J Antimicrob Chemother;
76(11): 3069, 2021 Oct 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34532730
8.
Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.
Antimicrob Agents Chemother;
57(12): 6122-30, 2013 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24080655
9.
Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies.
Infect Dis Ther;
11(2): 853-870, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35184255
10.
Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc.
Clin Infect Dis;
53(7): 732-42, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21890778
11.
Heterogeneity of Recent Phase 3 Complicated Urinary Tract Infection Clinical Trials.
Open Forum Infect Dis;
8(3): ofab045, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33738315
12.
Structured patient interview to assess clinical outcomes in complicated urinary tract infections in the APEKS-cUTI study: pilot investigation.
Ther Adv Infect Dis;
8: 20499361211058257, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34868583
13.
Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial.
J Pediatric Infect Dis Soc;
10(4): 477-484, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33340316
14.
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Lancet Infect Dis;
21(2): 226-240, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33058795
15.
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
Lancet Infect Dis;
20(10): 1204-1214, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32526195
16.
Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study.
Antiviral Res;
163: 75-81, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30684563
17.
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial.
Lancet Infect Dis;
18(12): 1319-1328, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30509675
18.
Are disulfiram-like reactions associated with abacavir-containing antiretroviral regimens in clinical practice?
AIDS;
21(13): 1823-4, 2007 Aug 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17690585
19.
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures.
AIDS;
21(11): 1423-30, 2007 Jul 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17589188
20.
Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients.
J Interferon Cytokine Res;
37(3): 103-111, 2017 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28282271